Literature DB >> 11302968

Effects of octreotide on responses to colorectal distension in the rat.

X Su1, M B Burton, G F Gebhart.   

Abstract

BACKGROUND AND AIMS: It has been suggested that the analgesic effect of the somatostatin analogue octreotide in visceral pain involves peripheral mechanisms. We evaluated the effect of octreotide on responses to noxious colorectal distension in rats.
METHODS: In a behavioural study, pressor and electromyographic responses to colorectal distension were evaluated before and after intravenous or intrathecal administration of octreotide. In pelvic nerve afferent fibre recordings, responses of mechanosensitive fibres innervating the colon to noxious colorectal distension (80 mm Hg, 30 seconds) were tested before and after octreotide.
RESULTS: Octreotide was ineffective in attenuating responses to colorectal distension in either normal or acetic acid inflamed colon when administered intravenously but attenuated responses when given intrathecally. Administration of octreotide over a broad dose range (0.5 microg/kg to 2.4 mg/kg) did not alter responses of afferent fibres to noxious colorectal distension in untreated, or acetic acid or zymosan treated colons.
CONCLUSIONS: In the rat, octreotide has no peripheral (pelvic nerve) modulatory action in visceral nociception. The antinociceptive effect of octreotide in this model of visceral nociception is mediated by an action at central sites.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302968      PMCID: PMC1728284          DOI: 10.1136/gut.48.5.676

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  44 in total

1.  Role of sensitized pelvic nerve afferents from the inflamed rat colon in the maintenance of visceral hyperalgesia.

Authors:  S V Coutinho; X Su; J N Sengupta; G F Gebhart
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

2.  Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat.

Authors:  T Hökfelt; R Elde; O Johansson; R Luft; G Nilsson; A Arimura
Journal:  Neuroscience       Date:  1976       Impact factor: 3.590

3.  Ultrastructural evidence for the occurrence of two distinct somatostatin-containing systems in the substantia gelatinosa of rat spinal cord.

Authors:  A Ribeiro-da-Silva; A C Cuello
Journal:  J Chem Neuroanat       Date:  1990 Mar-Apr       Impact factor: 3.052

4.  Octreotide: a potent new non-opiate analgesic for intrathecal infusion.

Authors:  Richard D Penn; Judith A Paice; Jeffrey S Kroin
Journal:  Pain       Date:  1992-04       Impact factor: 6.961

5.  Neurobehavioral effects of intrathecal somatostatinergic treatment in subhuman primates.

Authors:  R Leblanc; S Gauthier; M Gauvin; R Quirion; R Palmour; H Masson
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

6.  Somatostatin: evidence for a role in thermal nociception.

Authors:  C R Morton; W D Hutchison; I A Hendry; A W Duggan
Journal:  Brain Res       Date:  1989-05-29       Impact factor: 3.252

7.  Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology.

Authors:  D M Gaumann; T L Yaksh; C Post; G L Wilcox; M Rodriguez
Journal:  Anesth Analg       Date:  1989-05       Impact factor: 5.108

8.  The binding of bombesin and somatostatin and their analogs to human colon cancers.

Authors:  S S Radulovic; S R Milovanovic; R Z Cai; A V Schally
Journal:  Proc Soc Exp Biol Med       Date:  1992-07

9.  A quantitative study of the coexistence of peptides in varicosities within the superficial laminae of the dorsal horn of the rat spinal cord.

Authors:  M M Tuchscherer; V S Seybold
Journal:  J Neurosci       Date:  1989-01       Impact factor: 6.167

10.  Spinal somatostatin superfusion in vivo affects activity of cat nociceptive dorsal horn neurons: comparison with spinal morphine.

Authors:  J Sandkühler; Q G Fu; C Helmchen
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

View more
  11 in total

1.  Some of the challenges in drug development for irritable bowel syndrome.

Authors:  E A Mayer
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

3.  Electroacupuncture reduces rectal distension-induced blood pressure changes in conscious dogs.

Authors:  Masahiro Iwa; Carmen Strickland; Yukiomi Nakade; Theodore N Pappas; Toku Takahashi
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

4.  Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice.

Authors:  Agata Mulak; Muriel Larauche; Mandy Biraud; Mulugeta Million; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2014-11-05       Impact factor: 3.750

Review 5.  The role of experimental models in developing new treatments for irritable bowel syndrome.

Authors:  Daniel P Holschneider; Sylvie Bradesi; Emeran A Mayer
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 3.869

6.  Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans.

Authors:  A Foxx-Orenstein; M Camilleri; D Stephens; D Burton
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

Review 7.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

8.  Spontaneous hypersensitivity in mesenteric afferent nerves of mice deficient in the sst2 subtype of somatostatin receptor.

Authors:  Weifang Rong; Wendy J Winchester; David Grundy
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

9.  TRPV1 receptors on unmyelinated C-fibres mediate colitis-induced sensitization of pelvic afferent nerve fibres in rats.

Authors:  H U De Schepper; B Y De Winter; L Van Nassauw; J-P Timmermans; A G Herman; P A Pelckmans; J G De Man
Journal:  J Physiol       Date:  2008-08-28       Impact factor: 5.182

10.  Inhibition of visceral nociceptors.

Authors:  David E Reed; L Ashley Blackshaw
Journal:  Front Pharmacol       Date:  2014-04-14       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.